Christopher O'Brien

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,654,142
- Issue date May 23, 2023
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,439,629
- Issue date Sep 13, 2022
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High dosage valbenazine formulation and compositions, methods, and...
- Patent number 11,311,532
- Issue date Apr 26, 2022
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,040,029
- Issue date Jun 22, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,026,931
- Issue date Jun 8, 2021
- Neurocrine Biosciences, Inc.
- Grace S. Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,993,941
- Issue date May 4, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,952,997
- Issue date Mar 23, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,912,771
- Issue date Feb 9, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,874,648
- Issue date Dec 29, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,857,148
- Issue date Dec 8, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,857,137
- Issue date Dec 8, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
- Publication number 20210196702
- Publication date Jul 1, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20210169862
- Publication date Jun 10, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...
- Publication number 20210113553
- Publication date Apr 22, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20210046060
- Publication date Feb 18, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20210038593
- Publication date Feb 11, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Dosage Valbenazine Formulation and Compositions, Methods, and...
- Publication number 20210030744
- Publication date Feb 4, 2021
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20210030742
- Publication date Feb 4, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Dosage Valbenazine Formulation and Compositions, Methods, and...
- Publication number 20210030743
- Publication date Feb 4, 2021
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS
- Publication number 20200360354
- Publication date Nov 19, 2020
- Neurocrine Biosciences, Inc.
- Grace S. Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200338066
- Publication date Oct 29, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Dosage Valbenazine Formulation and Compositions, Methods, and...
- Publication number 20200276184
- Publication date Sep 3, 2020
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200268745
- Publication date Aug 27, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200268743
- Publication date Aug 27, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200268724
- Publication date Aug 27, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200268744
- Publication date Aug 27, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200268725
- Publication date Aug 27, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200230127
- Publication date Jul 23, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF VALBENAZINE FOR TREATING LEVODOPA-INDUCED DYSKINESIA
- Publication number 20200179352
- Publication date Jun 11, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
- Publication number 20200101063
- Publication date Apr 2, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20200093808
- Publication date Mar 26, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...
- Publication number 20200078352
- Publication date Mar 12, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20190381016
- Publication date Dec 19, 2019
- Neurocrine Biosciences, Inc.
- Christopher F. O`Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VMAT2 INHIBITORS FOR TREATING NEUROLOGICAL DISEASES OR DISORDERS
- Publication number 20190015396
- Publication date Jan 17, 2019
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
- Publication number 20170071932
- Publication date Mar 16, 2017
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Nerve Entrapment Syndromes
- Publication number 20080171065
- Publication date Jul 17, 2008
- Christopher O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating nerve entrapment syndromes
- Publication number 20030224019
- Publication date Dec 4, 2003
- Christopher O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher O'Brien

Person

Patents Grantslast 30 patents

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

High dosage valbenazine formulation and compositions, methods, and...

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Patents Applicationslast 30 patents

TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS

Methods for the Administration of Certain VMAT2 Inhibitors

Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

High Dosage Valbenazine Formulation and Compositions, Methods, and...

Methods for the Administration of Certain VMAT2 Inhibitors

High Dosage Valbenazine Formulation and Compositions, Methods, and...

METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS

Methods for the Administration of Certain VMAT2 Inhibitors

High Dosage Valbenazine Formulation and Compositions, Methods, and...

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

Methods for the Administration of Certain VMAT2 Inhibitors

USE OF VALBENAZINE FOR TREATING LEVODOPA-INDUCED DYSKINESIA

TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS

Methods for the Administration of Certain VMAT2 Inhibitors

Use of Valbenazine for Treating Schizophrenia or Schizoaffective Di...

Methods for the Administration of Certain VMAT2 Inhibitors

VMAT2 INHIBITORS FOR TREATING NEUROLOGICAL DISEASES OR DISORDERS

TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS

Methods of Treating Nerve Entrapment Syndromes

Methods of treating nerve entrapment syndromes